FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

VIVIMEDLAB Share Price Discussion

Vivimed Labs Ltd.
Sector: Pharmaceuticals and health care
... Read more
VIVIMEDLAB Long Term Analysts Rating
0/5 (0 Ratings)
VIVIMEDLAB Share Price *
12.65 -0.35 (-2.69%)
* (quote may be delayed)

Find answers to all your questions on live VIVIMEDLAB message board: Is VIVIMEDLAB buy or sell? Should I buy VIVIMEDLAB shares? Why are VIVIMEDLAB shares falling? Should I invest in VIVIMEDLAB stock?


You can also check VIVIMEDLAB share price target recommended by brokerages.

VIVIMEDLAB Discussion Forum

@newsbot • Reputation: 1,933
Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Shilpa Medicare, Avenue Supermarts
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Varun Beverages, Avenue Supermarts
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
  • VIVIMEDLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization193.05
    Enterprise Value1,022.48
    Price to Earnings59.39
    Price to Book Value0.34
    Return on Capital Employed0.06
    Return on Equity0.02
    Face Value2
    Dividend Yield0.01
  • VIVIMEDLAB Share Price - Technicals

    keyboard_arrow_down
    VIVIMEDLAB - 52 Week High₹28.25
    VIVIMEDLAB - 52 Week Low₹10.15
  • VIVIMEDLAB - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    5-Mar-18KRChokseyBuy134
    VIVIMEDLAB Brokerage Price Target
  • VIVIMEDLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 2213.113.212.6512.75
    Jan 2113.313.6512.8513
    Jan 2013.0514.513.0513.35
    Jan 1712.2512.512.0512.25
    Jan 1612.312.8512.312.45
  • VIVIMEDLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹12.55
    30 Day Moving Average₹12.55
    50 Day Moving Average₹12.59
    100 Day Moving Average₹13.88
    200 Day Moving Average₹16.68
  • VIVIMEDLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue261.39569.84-0.54
    Operating Profit78.34259.67-0.7
    Profit Before Tax8.86181.44-0.95
    Net Income9.87132.68-0.93
  • VIVIMEDLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds572.62529.410.08
    Total Liabilities581.94726.01-0.2
    Total Assets1,154.561,255.42-0.08
  • VIVIMEDLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity206.55242.45-0.15
    Cash from Investing Activity-38.1241.35-1.92
    Cash from Financing Activity-174.8-275.42-0.37
    Net Cash Flow-6.388.38-1.76
  • VIVIMEDLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.010.1
    Return on Equity0.020.26
    Return on Capital Employed0.060.22
  • VIVIMEDLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.39
    3 Year CAGR Growth in Operating Profit-0.29
    3 Year CAGR Growth in EBIDTA-0.28
    3 Year CAGR Growth in Net Income-0.48
    3 Yr CAGR Growth - Diluted EPS-0.9
  • VIVIMEDLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.38
    5 Year CAGR Growth in Operating Profit-0.17
    5 Year CAGR Growth in EBIDTA-0.18
    5 Year CAGR Growth in Net Income-0.73
    3 Yr CAGR Growth - Diluted EPS-0.95
  • VIVIMEDLAB - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 9 1:43 PM
    Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Shilpa Medicare, Avenue Supermarts
    Moneycontrol
    NewsBot
    Sep 9 1:13 PM
    Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Varun Beverages, Avenue Supermarts
    Moneycontrol
    NewsBot
    Aug 12 8:33 PM
    Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 12 8:33 PM
    Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y
    moneycontrol.com
    NewsBot
    May 31 10:38 PM
    NewsBot
    May 31 10:38 PM
    NewsBot
    Feb 15 9:42 PM
    NewsBot
    Feb 15 9:37 PM
    NewsBot
    Jan 31 1:37 AM
    NewsBot
    Nov 15 10:17 PM
  • VIVIMEDLAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Dr. Reddy's Laboratories Ltd. Sector...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Divi's Laboratories Ltd. Sector: Pha...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.